Thomson Medical
Listed on the Mainboard of the Singapore Exchange, Thomson Medical Group Limited is one of the leading listed healthcare players in the South-East Asian region with operations in Singapore and Malaysia.
See below for the Latest Thomson Medical News, Analysis, Profit Results, Share Price Information, and Commentary.
Thomson Medical commercial chief Cassandra Loh named Singapore CEO
It will take effect on 1 July.
Tong Kooi Ong replaces Ng Ser Miang as Thomson chair
The leadership change takes effect 1 February following Ng Ser Miang’s resignation.
Thomson Medical posts $47m net loss in FY2025
Group revenue rose 12.4% to $394.7m.
Thomson Medical Singapore launches new centre for cancer care
The facility will officially open to patients in July.
Thomson Medical Group prices $25m fixed rates notes due 2029
The notes are offered at 4.65% per annum.
Thomson Medical to provide benefits for Great Eastern Life policyholders
Policyholders will have access to specialist treatments at Thomson Medical Centre.
Thomson Medical Group incurs $12.6m net loss for H1 2025
Revenue amounted to $199.1m for the period.
Thomson Medical Group expects loss for H1
This is primarily due to weaker performance in the Malaysia market.
Thomson Medical partners with Adyen for integrated payments
The healthcare group’s patients can pay using their preferred modes and currencies.
Thomson Medical to issue $160m notes at 4.65% fixed rate
The notes are due in 2029.
Thomson Medical unveils urgent care centre for non-emergency conditions
The facility offers diagnostic services supported by the Thomson Diagnostic Imaging Centre.
Thomson Medical’s FY2024 earnings plunges 57.8% to $15.4m
Earnings per share stood at $0.058.
Thomson Medical issues $155m notes at 5.25%
These will be listed on the SGX on 14 May 2024.
Thomson Medical restores public float to 10.15%
It sold 50 million shares to meet the minimum public float requirement.
Thomson Medical’s profit dwindles to $2m in 1H24
The healthcare provider also recorded lower revenue during the period.
Thomson Medical granted 3 months extension to restore public float
SGX previously rejected the company’s appeal for an extension.
Read Here
Advertise
Sign Up
![[Singapore Business Review] Report on the Asian Business Channel](https://www.cmgassets.com/s3fs-public/styles/video_thumbnail/public/2026-10/full-show-thumbnail_1.png.webp?VersionId=bJbrT_JKOuMWBnf7YkmsWjOSWIXddSvY&itok=zWuxHRNG)
Commentary
Singapore’s small exporters need credit that matches their payment cycle
The hidden realities of succession for next-gen heirs
In Asia, fintech leaders must compete on credibility
F1 on a gravel road: Why AI is still stuck in first gear
Why AI blocklists give Singapore firms a false sense of security
When scale arrives before proof: Singapore’s capital allocation question in Southeast Asia
Rethinking fleet ownership in a changing business landscape
Beyond the chips: The materials behind Singapore’s AI infrastructure
How homegrown brands are redefining premium in Asia
AI in hospitality: Where should Singapore’s F&B operators draw the line?